por
Soeroto, Arto Yuwono,
Lestari, Bony Wiem,
Santoso, Prayudi,
Chaidir, Lidya,
Andriyoko, Basti,
Alisjahbana, Bachti,
van Crevel, Reinout,
Hill, Philip C.
Publicado 2019
“…BACKGROUND: Rifampicin-resistant tuberculosis (RR-TB) is largely underdetected in
Indonesia. Xpert MTB/RIF (Xpert) has recently been introduced, prioritizing patients at risk of RR-TB, followed by phenotypic drug-susceptibility (DST) if rifampicin resistance is detected. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online
Artículo
Texto